News + Filings Holdings
|
VR Adviser, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Viridian Therapeutics, Inc.\DE
| VRDN | COM | 3,082,622 | 382,757 | 73,335,577,000 | -5,527,480,000 | 11.73 | 7.15 |
Hist
| 06/30/2023 |
Cogent Biosciences, Inc.
| COGT | Common | 4,684,132 | 646,015 | 55,460,123,000 | 8,779,490,000 | 8.87 | 6.60 |
Hist
| 06/30/2023 |
4D Molecular Therapeutics, Inc.
| FDMT | Common | 3,000,000 | 3,000,000 | 54,210,000,000 | 54,210,000,000 | 8.67 | 9.02 |
Hist
| 06/30/2023 |
Enliven Therapeutics, Inc.
| ELVN | Common | 2,230,127 | 2,230,127 | 45,516,892,000 | 45,516,892,000 | 7.28 | 5.42 |
Hist
| 06/30/2023 |
Merus N.V.
| MRUS | COM | 1,726,214 | 500,000 | 45,451,215,000 | 26,481,684,000 | 7.27 | |
Hist
| 06/30/2023 |
GH Research PLC
| GHRS | Common | 3,517,125 | 0 | 41,730,688,000 | 7,544,233,000 | 6.67 | 6.76 |
Hist
| 06/30/2023 |
Ambrx Biopharma Inc.
| AMAM | SPONSORED ADS | 2,484,960 | 2,484,960 | 40,902,442,000 | 40,902,442,000 | 6.54 | |
Hist
| 06/30/2023 |
KalVista Pharmaceuticals, Inc.
| KALV | Common | 2,916,667 | 0 | 26,250,003,000 | 6,533,334,000 | 4.20 | 8.52 |
Hist
| 06/30/2023 |
Terns Pharmaceuticals, Inc.
| TERN | Common | 2,972,869 | -735,022 | 26,012,604,000 | -11,733,726,000 | 4.16 | 5.24 |
Hist
| 06/30/2023 |
Cabaletta Bio, Inc.
| CABA | Common | 1,973,251 | 77,966 | 25,474,670,000 | 7,943,284,000 | 4.07 | 6.29 |
Hist
| 06/30/2023 |
Dyne Therapeutics, Inc.
| DYN | Common | 2,173,913 | 2,173,913 | 24,456,521,000 | 24,456,521,000 | 3.91 | 3.73 |
Hist
| 06/30/2023 |
Celcuity Inc.
| CELC | COM | 2,105,386 | 0 | 23,117,138,000 | -6,379,320,000 | 3.70 | 9.59 |
Hist
| 06/30/2023 |
Savara Inc
| SVRA | Common | 6,351,531 | 0 | 20,293,142,000 | 10,448,269,000 | 3.25 | 5.57 |
Hist
| 06/30/2023 |
Pharvaris N.V.
| PHVS | Common | 1,326,200 | 1,326,200 | 20,078,668,000 | 20,078,668,000 | 3.21 | 3.92 |
Hist
| 06/30/2023 |
RHYTHM PHARMACEUTICALS, INC.
| RYTM | Common | 1,090,000 | 1,090,000 | 17,974,100,000 | 17,974,100,000 | 2.87 | 1.92 |
Hist
| 06/30/2023 |
Oric Pharmaceuticals, Inc.
| ORIC | Common | 2,142,856 | 2,142,856 | 16,628,563,000 | 16,628,563,000 | 2.66 | 4.75 |
Hist
| 06/30/2023 |
Aclaris Therapeutics, Inc.
| ACRS | COM | 1,040,754 | -3,523,208 | 10,792,619,000 | -61,089,783,000 | 1.73 | 1.47 |
Hist
| 06/30/2023 |
Trevi Therapeutics, Inc.
| TRVI | Common | 3,422,397 | 372,375 | 8,179,529,000 | 2,292,987,000 | 1.31 | 5.70 |
Hist
| 06/30/2023 |
Applied Therapeutics Inc.
| APLT | Common | 5,658,034 | 5,658,034 | 7,242,284,000 | 7,242,284,000 | 1.16 | 9.78 |
Hist
| 06/30/2023 |
Theseus Pharmaceuticals, Inc.
| THRX | Common | 770,000 | 770,000 | 7,184,100,000 | 7,184,100,000 | 1.15 | 1.77 |
Hist
| 06/30/2023 |
Milestone Pharmaceuticals Inc.
| MIST | Common | 2,208,812 | 0 | 6,295,114,000 | -2,451,782,000 | 1.01 | 6.62 |
Hist
| 06/30/2023 |
Adverum Biotechnologies, Inc.
| ADVM | COM | 3,886,246 | 3,886,246 | 6,179,131,000 | 6,179,131,000 | 0.99 | 3.86 |
Hist
| 06/30/2023 |
Praxis Precision Medicines, Inc.
| PRAX | COM | 5,304,410 | 5,304,410 | 6,100,072,000 | 6,100,072,000 | 0.98 | 8.54 |
Hist
| 06/30/2023 |
PLIANT THERAPEUTICS, INC.
| PLRX | Common | 288,949 | -791,051 | 5,235,756,000 | -15,640,644,000 | 0.84 | 0.49 |
Hist
| 06/30/2023 |
Lyra Therapeutics, Inc.
| LYRA | Common | 924,170 | 0 | 3,798,339,000 | 896,445,000 | 0.61 | 2.90 |
Hist
| 06/30/2023 |
Aeglea BioTherapeutics, Inc.
| AGLE | COM | 6,343,221 | 6,343,221 | 2,857,621,000 | 2,857,621,000 | 0.46 | 9.70 |
Hist
| 06/30/2023 |
Black Diamond Therapeutics, Inc.
| BDTX | Common | 353,629 | 353,629 | 1,785,826,000 | 1,785,826,000 | 0.29 | 0.97 |
Hist
| 06/30/2023 |
Rallybio Corp
| RLYB | Common | 268,532 | 0 | 1,519,891,000 | -244,364,000 | 0.24 | 0.71 |
Hist
| 06/30/2023 |
Affimed N.V.
| AFMD | COM | 1,428,571 | 0 | 854,571,000 | -916,857,000 | 0.14 | 0.96 |
Hist
| 06/30/2023 |
Avalo Therapeutics, Inc.
| AVTX | COM NEW | 1,250,000 | 1,250,000 | 444,000,000 | 444,000,000 | 0.07 | 9.47 |
Hist
| 06/30/2023 |
LianBio
| LIAN | SPONSORED ADS | 0 | -4,793,047 | 0 | -7,860,597,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
DBV Technologies S.A.
| DBVT | SPONSORED ADR | 0 | -9,300,000 | 0 | -29,257,800,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Annexon, Inc.
| ANNX | Common | 0 | -3,220,050 | 0 | -16,647,659,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Inozyme Pharma, Inc.
| INZY | Common | 0 | -2,709,987 | 0 | -2,845,486,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
NOVAVAX INC
| NVAX | COMMON | 0 | -1,879,894 | 0 | -19,325,310,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
<< Prev Next >> |
|
|
|
|